Global Pet Veterinary Drug Market Growth 2024-2030

Publication ID:

LPI03250694

Publication Date:

March 13, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pet Veterinary Drug market size was valued at US$ 8525.2 million in 2023. With growing demand in downstream market, the Pet Veterinary Drug is forecast to a readjusted size of US$ 12060 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global Pet Veterinary Drug market. Pet Veterinary Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pet Veterinary Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pet Veterinary Drug market.
Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 47%.
Key Features:
The report on Pet Veterinary Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pet Veterinary Drug market. It may include historical data, market segmentation by Type (e.g., Anti-Infectives, Anti-Inflammatory), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pet Veterinary Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pet Veterinary Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pet Veterinary Drug industry. This include advancements in Pet Veterinary Drug technology, Pet Veterinary Drug new entrants, Pet Veterinary Drug new investment, and other innovations that are shaping the future of Pet Veterinary Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pet Veterinary Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Pet Veterinary Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pet Veterinary Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pet Veterinary Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pet Veterinary Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pet Veterinary Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pet Veterinary Drug market.
Market Segmentation:
Pet Veterinary Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by application
Veterinary Hospitals
Veterinary Clinics
Drug Stores
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pet Veterinary Drug market?
What factors are driving Pet Veterinary Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Veterinary Drug market opportunities vary by end market size?
How does Pet Veterinary Drug break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Veterinary Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pet Veterinary Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pet Veterinary Drug by Country/Region, 2019, 2023 & 2030
2.2 Pet Veterinary Drug Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Pet Veterinary Drug Sales by Type
2.3.1 Global Pet Veterinary Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Pet Veterinary Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pet Veterinary Drug Sale Price by Type (2019-2024)
2.4 Pet Veterinary Drug Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Drug Stores
2.5 Pet Veterinary Drug Sales by Application
2.5.1 Global Pet Veterinary Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Pet Veterinary Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pet Veterinary Drug Sale Price by Application (2019-2024)
3 Global Pet Veterinary Drug by Company
3.1 Global Pet Veterinary Drug Breakdown Data by Company
3.1.1 Global Pet Veterinary Drug Annual Sales by Company (2019-2024)
3.1.2 Global Pet Veterinary Drug Sales Market Share by Company (2019-2024)
3.2 Global Pet Veterinary Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Pet Veterinary Drug Revenue by Company (2019-2024)
3.2.2 Global Pet Veterinary Drug Revenue Market Share by Company (2019-2024)
3.3 Global Pet Veterinary Drug Sale Price by Company
3.4 Key Manufacturers Pet Veterinary Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Veterinary Drug Product Location Distribution
3.4.2 Players Pet Veterinary Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Veterinary Drug by Geographic Region
4.1 World Historic Pet Veterinary Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Pet Veterinary Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pet Veterinary Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pet Veterinary Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Pet Veterinary Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pet Veterinary Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pet Veterinary Drug Sales Growth
4.4 APAC Pet Veterinary Drug Sales Growth
4.5 Europe Pet Veterinary Drug Sales Growth
4.6 Middle East & Africa Pet Veterinary Drug Sales Growth
5 Americas
5.1 Americas Pet Veterinary Drug Sales by Country
5.1.1 Americas Pet Veterinary Drug Sales by Country (2019-2024)
5.1.2 Americas Pet Veterinary Drug Revenue by Country (2019-2024)
5.2 Americas Pet Veterinary Drug Sales by Type
5.3 Americas Pet Veterinary Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Veterinary Drug Sales by Region
6.1.1 APAC Pet Veterinary Drug Sales by Region (2019-2024)
6.1.2 APAC Pet Veterinary Drug Revenue by Region (2019-2024)
6.2 APAC Pet Veterinary Drug Sales by Type
6.3 APAC Pet Veterinary Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Veterinary Drug by Country
7.1.1 Europe Pet Veterinary Drug Sales by Country (2019-2024)
7.1.2 Europe Pet Veterinary Drug Revenue by Country (2019-2024)
7.2 Europe Pet Veterinary Drug Sales by Type
7.3 Europe Pet Veterinary Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Veterinary Drug by Country
8.1.1 Middle East & Africa Pet Veterinary Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pet Veterinary Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Pet Veterinary Drug Sales by Type
8.3 Middle East & Africa Pet Veterinary Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Veterinary Drug
10.3 Manufacturing Process Analysis of Pet Veterinary Drug
10.4 Industry Chain Structure of Pet Veterinary Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Veterinary Drug Distributors
11.3 Pet Veterinary Drug Customer
12 World Forecast Review for Pet Veterinary Drug by Geographic Region
12.1 Global Pet Veterinary Drug Market Size Forecast by Region
12.1.1 Global Pet Veterinary Drug Forecast by Region (2025-2030)
12.1.2 Global Pet Veterinary Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Veterinary Drug Forecast by Type
12.7 Global Pet Veterinary Drug Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim International GmbH
13.1.1 Boehringer Ingelheim International GmbH Company Information
13.1.2 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boehringer Ingelheim International GmbH Main Business Overview
13.1.5 Boehringer Ingelheim International GmbH Latest Developments
13.2 Zoetis Animal Healthcare
13.2.1 Zoetis Animal Healthcare Company Information
13.2.2 Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolios and Specifications
13.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zoetis Animal Healthcare Main Business Overview
13.2.5 Zoetis Animal Healthcare Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Pet Veterinary Drug Product Portfolios and Specifications
13.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Pet Veterinary Drug Product Portfolios and Specifications
13.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Elanco Animal Health Inc.
13.5.1 Elanco Animal Health Inc. Company Information
13.5.2 Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolios and Specifications
13.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Elanco Animal Health Inc. Main Business Overview
13.5.5 Elanco Animal Health Inc. Latest Developments
13.6 Virbac Group
13.6.1 Virbac Group Company Information
13.6.2 Virbac Group Pet Veterinary Drug Product Portfolios and Specifications
13.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Virbac Group Main Business Overview
13.6.5 Virbac Group Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Pet Veterinary Drug Product Portfolios and Specifications
13.7.3 Ceva Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Dechra Pharmaceuticals Plc
13.8.1 Dechra Pharmaceuticals Plc Company Information
13.8.2 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolios and Specifications
13.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Dechra Pharmaceuticals Plc Main Business Overview
13.8.5 Dechra Pharmaceuticals Plc Latest Developments
13.9 Vetoquinol
13.9.1 Vetoquinol Company Information
13.9.2 Vetoquinol Pet Veterinary Drug Product Portfolios and Specifications
13.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Vetoquinol Main Business Overview
13.9.5 Vetoquinol Latest Developments
13.10 Orion Corporation
13.10.1 Orion Corporation Company Information
13.10.2 Orion Corporation Pet Veterinary Drug Product Portfolios and Specifications
13.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Orion Corporation Main Business Overview
13.10.5 Orion Corporation Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂